Remove Containment Remove FDA Approval Remove Filler Remove Research
article thumbnail

BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US

XTalks

Xtalks learned more about BONESUPPORT and its first FDA-approved drug-device combination product Cerament G through an email interview with BONESUPPORT’s CEO Emil Billbäck. Professor Lidgren is a well renowned orthopedic clinician, researcher and scientist. Read on to learn more! Please tell us about BONESUPPORT.

Filler 98